Your browser doesn't support javascript.
loading
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
Malek, Alexandre E; Al-Juhaishi, Taha; Milton, Denái R; Ramdial, Jeremy L; Daher, May; Olson, Amanda L; Srour, Samer A; Alatrash, Gheath; Oran, Betul; Mehta, Rohtesh S; Khouri, Issa F; Bashir, Qaiser; Shah, Nina; Ciurea, Stefan O; Rondon, Gabriela; Maadani, Farzaneh; Hosing, Chitra; Marin, David; Kebriaei, Partow; Rezvani, Katayoun; Nieto, Yago; Anderlini, Paolo; Alousi, Amin M; Faisal, Muhammad Salman; Qazilbash, Muzaffar H; Popat, Uday R; Champlin, Richard E; Shpall, Elizabeth J; Mulanovich, Victor E; Ahmed, Sairah.
Afiliação
  • Malek AE; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Al-Juhaishi T; Department of Medicine- Division of Infectious Diseases, Louisiana State University Health Shreveport, Shreveport, LA, USA.
  • Milton DR; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ramdial JL; OU Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Department of Medicine-Section of Hematology and Medical Oncology, Oklahoma City, OK, USA.
  • Daher M; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Olson AL; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alatrash G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Oran B; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mehta RS; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khouri IF; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shah N; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ciurea SO; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maadani F; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hosing C; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marin D; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Anderlini P; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alousi AM; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Faisal MS; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mulanovich VE; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ahmed S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bone Marrow Transplant ; 59(5): 699-704, 2024 May.
Article em En | MEDLINE | ID: mdl-38355908
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_neglected_diseases / 3_zoonosis Assunto principal: Toxoplasmose / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_neglected_diseases / 3_zoonosis Assunto principal: Toxoplasmose / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos